C. Vakoc
Cell · 2005–2019
A researcher in the Science corpus: 10 papers; trusts 0 researchers and is trusted by 7 researchers here, as inferred from the citation graph.
Who trusts C. Vakoc overall
Papers from C. Vakoc's perspective
Ordered by how strongly the researchers C. Vakoc trusts endorse each paper. Same corpus, a different order for every researcher.
- Suppression of inflammation by a synthetic histone mimic (Nature)
- Model-based Analysis of ChIP-Seq (MACS)
- A unique chromatin signature uncovers early developmental enhancers in humans (Nature)
- Histone H3K27ac separates active from poised enhancers and predicts developmental state (Proceedings of the National Academy of Sciences of the United States of America)
- The history of cancer epigenetics (Nature Reviews. Cancer)
- Targeting MYC dependence in cancer by inhibiting BET bromodomains (Proceedings of the National Academy of Sciences of the United States of America)
- The Double Bromodomain-containing Chromatin Adaptor Brd4 and Transcriptional Regulation* (Journal of Biological Chemistry)
- Histone Modifications at Human Enhancers Reflect Global Cell Type-Specific Gene Expression (Nature)
- Enhancer function: new insights into the regulation of tissue-specific gene expression (Nature reviews genetics)
- Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes (Cell)
Their papers
- BET bromodomain inhibition as a therapeutic strategy to target c-Myc (2011) — 2,801 citations
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers (2013) — 2,748 citations
- Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin. (2005) — 738 citations
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia (2011) — 1,853 citations
- Histone H3 Lysine 9 Methylation and HP1γ Are Associated with Transcription Elongation through Mammalian Chromatin. (2005) — 109 citations
- Promoter-bound METTL3 maintains myeloid leukaemia via m6A-dependent translation control (2017) — 982 citations
- Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains (2015) — 706 citations
- The mechanisms behind the therapeutic activity of BET bromodomain inhibition (2014) — 854 citations
- Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data (2019) — 1,052 citations
- Organoid profiling identifies common responders to chemotherapy in pancreatic cancer (2018) — 839 citations